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Abstract 
Background 
Echocardiography is the standard clinical approach for quantification of the severity 
of aortic stenosis. A comprehensive examination of its overall reproducibility and the 
simultaneous estimation of its variance components by multiple operators, readers, 
probe applications, and beats have not been undertaken. Such knowledge is key for 
three groups of people. Guideline authors need to be able to both state what level of 
precision can be expected with a technique, and provide evidence-based steps to 
improve the precision. Clinicians need such data so that they can differentiate true 
biological changes from random noise. Researchers need such data for both 
designing and powering trials, and developing targeted techniques to improve their 
precision. 
Method + Results 
As part of a quality improvement program, 27 subjects with aortic stenosis were 
scanned over 7 months in the echo-department by myself and a median of 2 other 
operators (range 1 to 3). From each patient and each operator multiple runs of beats 
from multiple probe positions were stored for later analysis by multiple readers. A 
mixed effects model was constructed to extract the variance components. 
The coefficient of variation was 13.3%, 15.9%, 17.6%, and 20.2% for the aortic peak 
velocity (Vmax), and velocity time integral (VTI), and left ventricular outflow tract 
(LVOT) Vmax and VTI respectively. The largest individual contributors to the overall 
variability were the beat-to-beat variability (9.0%, 9.3%, 9.5%, 9.4% respectively) and 
that of inability of an individual operator to precisely apply the probe to the same 
position twice (8.3%, 9.4%, 12.9%, 10.7% respectively). The tracing (inter-reader) 
and reader (inter-reader), and operator (inter-operator) contribution were less 
important. 
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Conclusions  
This thesis found that the reproducibility of measurements in aortic stenosis is poorer 
than often reported in the literature. However, it is comparable with a retrospective 
study I have previously participated in. Furthermore, the large variability of these 
simple parameters makes composite measurements for the assessment of the 
severity of aortic stenosis even more unreliable. The source of this variability does 
not appear, as traditionally believed, to result from a lack of training or operator and 
reader specific factors. Rather the unavoidable beat-to-beat biological variability, and 
the inherent impossibility of applying the ultrasound probe in exactly the same 
position each time are the largest contributors.  
Consequently, guidelines suggesting greater standardisation of procedures and 
further training for sonographers are unlikely to result in an improvement in precision. 
Clinicians themselves should be wary of relying on even three-beat averages as their 
expected coefficient of variance is 10.3% for the peak velocity at the aortic valve. 
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Introduction 
Echocardiography is the standard clinical approach for the quantification of aortic 
stenosis, both at baseline and at follow-up. While echocardiographic follow-up of 
aortic stenosis severity is recommended by every national and international 
guideline, the test-retest variability of this is actually rather poor(1), although 
discussion of this seems to be a “taboo”. 
The science of aortic stenosis measurement suffers from two weaknesses. First 
measurement technologies that have not undergone detailed, dispassionate analysis 
of their measurement properties are taken straight through to end-point studies, and 
become a guidelines recommended standard. Secondly, test-retest variability is not 
directly taken into consideration by guidelines and mention of such variability is 
answered by advice to undergo further training. 
In this thesis I set out to address under formal, blinded, scientific conditions how 
large the variability between one measurement of aortic stenosis and another 
actually is. I designed the experiment to permit the sources of variability to be 
decomposed so that we would be able to give sensible advice to those seeking more 
reliable measurements – trying to do something more specific than to “undergo more 
training”. 
 
Test-retest variability 
The true test-retest variability of the various measures of aortic stenosis is much 
higher than previously thought. I participated in a retrospective review of repeated 
echocardiograms in 70 patients with aortic stenosis(1) which demonstrated that the 
coefficient of variation for the simplest estimate of the gradient, the peak 
instantaneous pressure drop, was 19.1%. The dimensionless index using VTI, 
traditionally thought to be more accurate as it corrects for ventricular function, was 
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higher still at 25%. The variabilities of mean trans-aortic pressure drop and left 
ventricular outflow tract VTI were no better; 26.9% and 22.1% respectively(1).  
These values contrast to those typically quoted in the literature of 3-4 %(2) 
The following questions were left open: 
1) Were these findings a consequence of its retrospective design and the scans not 
having being originally acquired for research purposes? 
2) Could this have been explained by some element of disease progression over time 
since there was up to several months between successive scans? 
3) Is the variability really caused by inadequate training or are there some 
fundamental components which can be separated and quantified, as an essential 
step to reducing their impact? 
 
Guidelines 
The European Society of Cardiology guidelines for the assessment of aortic 
stenosis(3), in addition to the simple maximum aortic velocity which requires one 
measurement to be made, details eleven other composite measures that can be 
used for assessing the severity of aortic stenosis; one of which requires 5 different 
parameters to be measured. 
The test-retest variability of composite measures will be greater than those simple 
ones as errors are propagated and compounded through an equation (unless the 
errors are significantly correlated). Therefore, the addition of further parameters to a 
measure to “correct” for other sources of error such as left ventricular dysfunction 
may actually worsen the accuracy of the measure. This may explain why the clinical 
utility of these more complex measures is less than initially believed(2). 
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Identifying a measure 
It is inadequate to advise echocardiographers to make numerous measurements 
without a clear algorithm about what to do with the different results, since there will 
almost always be discrepancy between the grading categorisations between different 
variables(4). Typically echocardiographers are advised to use their clinical judgement, 
which is understandable advice in the absence of evidence that could suggest 
something more meaningful. In a research environment where echocardiography is 
used as a measurement, for entrance criteria, or as an endpoint, it is unacceptable 
for the echocardiographer to incorporate other information into a variable that is then 
presented as if it were a pure echocardiographic measurement. 
When individual measurements are too variable they will never be a reliable basis for 
the categorisation of individual patients or as an end-point measurement for 
individual patients(5). 
 
Reliable measurements 
Instead of recommending piling one unreliable measurement upon another, it is more 
rational to carefully assess why the measurements are unreliable in order to 
determine whether reliability can be improved. 
To select the most appropriate measure, it is essential for clinicians to be provided 
with the appropriate test-retest variability. In addition, researchers in 
echocardiography who hope to improve the reliability of aortic stenosis severity 
assessment also need information on its constituent components. Within 
echocardiography these components of variation that can be attributed to either 
analytical or temporal (biological) variability. The analytical component will comprise 
of differences in interpreting the Doppler tracings (intra-reader and inter-reader), and 
the small changes in the probe position that the same and different operators will 
obtain (intra-operator and inter-operator). The temporal component will operate on 
   8	  
different time-scales: beat-to-beat reflecting fluctuations in autonomic activation; day-
by-day reflecting filling; and over longer time periods [Figure 1] 
Unfortunately, credible prospective data assessing the true test-retest variability and 
its constituent components is lacking in echocardiography. Whilst some studies 
report presenting reproducibility data, on close examination it is very rarely formal, 
blinded, test-retest variability. The most common type of reproducibility data is 
remeasuring the same stored traced, either by the same reader or a different reader, 
and these characteristically are reported as a showing an extremely strong 
agreement. However, such reports omit most of the scientifically relevant variability, 
as shown in the figure above. 
 
Language of quantification  
For some reason, reproducibility reports often emphasise the correlation coefficient 
between the two repeated measurements. This statistic is a composite of two pieces 
of information: 
1) The variability of the measurement. 
2) The range of the variable in the patients tested. 
It is an unsatisfactory summary of reproducibility for two reasons. First, the breadth of 
the spectrum of patients has an overwhelming effect on the correlation coefficient 
observed. If the spectrum is wide, including very mildly diseased and very severely 
disease, the correlation coefficient is forced to be high even if the measurement 
technique is poorly reproducible. Second, it does not present variability in units that 
allow a clinician to determine for an individual patient what the uncertainty is(6). 
This is in contrast to other physical sciences which use well established experimental 
designs and modern statistical methods to estimate the reproducibility of 
measurement device(7); with national laboratories, such as NIST, which provide 
blinded and unbiased assessment culminating in an estimate of both the overall 
precision of a measurement device and its constituent components. 
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We therefore designed and conducted a reproducibility experiment aiming to use 
such techniques to simultaneously estimate both the total test-retest variability and its 
constituent components [Figure 1]: 
 
Tracing 
Working from the same frozen acquired Doppler image, the same reader is asked to 
trace around the same beat on three occasions with enough time elapsing and 
intervening beats measured for there to be no realistic possibility for the reader 
remembering exactly how he or she decided to trace around the beat on the previous 
occasion. This is sometimes called intra-reader variability. 
Beat-to-beat 
If the same reader is asked to analyse successive beats acquired in a single Doppler 
run, the two measurements will of course be different. It is important to note that 
there are two contributors to this difference. The more obvious component is that due 
to the change of beat. However, the second component will always be present, 
namely, the variability due to the act of tracing. 
The only way to extract the component specifically due to the beat-to-beat difference 
is to start overall observed variability between beats and then subtract the variability 
when the same beat is measured twice. In statistical terms this subtraction is valid if 
the variability is measured as a variance, i.e. the square of the standard deviation. 
In figure 1, the overall variance observed in the beat-to-beat experiment is composed 
of the tracing component (purple) and the true beat-to-beat component (red). The 
true beat-to-beat component can only be calculated by subtracting the tracing 
component (purple) from the overall beat-to-beat variability (red + purple). 
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Reader 
A second reader carrying out a tracing will obtain different values from the first. 
However, contrary to common belief amongst Authors, this should not be assumed to 
be the result of the junior of the two operators being inadequately trained to match 
the senior operator. It could simply be a manifestation of the within reader variability 
of each. In general it is not reasonable to expect two readers to agree with each 
other, better than each agrees with themselves. If they do agree better with each 
other, better than with themselves, this is likely due to inadvertent collusion. If they 
agree just as well with each other as they do with themselves, there is no difference 
attributable to the difference in reader, only the variability introduced by having the 
tracing performed by anyone.  
As long as the same beat is being addressed, it is only the tracing variability that is 
must be subtracted. 
If on the other hand the new reader is only able to address a new beat, then the total 
observed variability observed in that experiment is a combination of three 
components: tracing (purple), beat-to-beat (red), reader (blue). It will be therefore 
necessary to subtract the tracing and beat variabilities to obtain the pure reader 
variability. 
 
 
Position 
Working backwards to the time of acquisition, the exact position of the probe is 
unique for each acquisition and can never be perfectly reproduced even with a high 
level of training. To determine how much variability this causes step of probe 
positioning causes it is not sufficient to repeatedly do measurements placed afresh 
onto the chest each time. This is because any observed difference between probe 
placements will always include variability arising from tracing (purple) and from beat-
to-beat (red). These latter two components must always be subtracted from the 
experimental variability to obtain the true variability arising from probe position 
(orange). 
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Operator 
If a second operator acquires data in the same patient, the measurements will be 
different, but of course, the probe will be in a different position, the heart beats will be 
different, and it will be a separate process of tracing. Therefore to determine the true, 
incremental effect of changing operator, one must subtract the variability due to 
probe position (orange), beat-to-beat variability (red), and tracing (purple). 
Conveniently this can be done by subtracting when one operator removes the probe 
from the chest, puts it back, and makes a fresh measurement, i.e. the experiment 
described above as “position”. 
Clinical status 
There can be some genuine change over time in the status of patients. For example, 
over a period of weeks or months, the disease can progress, or, theoretically improve 
Moreover, over short periods of time changes in volume status can increase or 
decrease velocities. Treatment effects can also occur, over short, medium, or longer-
terms. 
In my study I decided to specifically set these potential sources of variability aside 
and focus exclusively on an accurate assessment of the five components shown 
above. 
 
Experimental design required 
In my pilot studies(1) with my colleagues Dr. Finegold and Dr. Manisty we observed 
the large variability in a retrospectively analysed dataset. I decided to carry out a 
quality improvement program within our echocardiography department. I arranged 
that whenever I was in the echo laboratory and a patient with aortic stenosis in sinus 
rhythm was scanned, I ensured that the LVOT and aortic valve velocities were 
measured from more than one probe position, and by more than one operator, 
typically three. The clinical report was then issued by the primary operator after 
viewing all the acquired data using a standard approach. The acquired data were 
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then anonymised with respect to patient identity, beat-sequence, probe position 
iteration, and operator and subjected to further analysis to extract the components 
shown in Figure 1. 
I decided to address the variability of the key measurements - peak velocity (Vmax) 
and velocity time integral (VTI) at the aortic valve (AV) and left ventricular outflow 
tract (LVOT). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   13	  
METHODS 
Patients attending an echocardiography department at a tertiary-referral centre in 
London for routine surveillance of known aortic stenosis underwent a standard echo 
according BSE guidelines(8) by myself, a consultant in cardiology with particular 
interest in echocardiography. After performing a standard BSE echo(8), continuous-
wave tracings across the aortic valve and pulse-wave tracings of the LVOT were 
taken in the five-chamber view. Once a satisfactory position had been obtained, 
rather than selecting a single beat, and performing on-line measurement, long runs 
(up to 15) of beats were captured and stored for off-line, blinded, analysis. The probe 
was then removed from and then reapplied to the patient, before capturing another 
run of beats. For each patient two to three other accredited sonographers captured 
continuous and pulse wave traces in a similar manner. 
All images were exported as TIFFs and anonymised with respect to patient 
demographics. For each beat an image was generated that removed all other beats, 
leaving only it and the calibration markings. The operator, position, beat number, 
along with calibration data were entered into a database and then identifiers were 
removed from the image. Images were then screened for quality. No whole patient, 
operator, or position were excluded from the database, but 16/1880 (<1%) were 
considered to be of poor quality to prevent further analysis. Images were then 
analysed using an imaging software(9) to select the maximum velocity, and VTI on a 
15 inch MacBook Pro (Apple Inc., California, USA) in a darkened room. 
Sonographers were given the choice of using a mouse or trackball. An independent 
statistician and programmer designed software and protocols to present appropriate 
images to readers randomised and blinded to the patient, operator, position, and beat 
number. I traced every image selecting the Vmax and tracing the VTI independently, 
whilst multiple sonographers reviewed a selection (123) beats evenly distributed 
across patients and operators measuring both the Vmax and VTI. 
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The measurement data was then combined with the database describing the origin of 
the images within R (Version 2.15.1). A mixed-effects model was generated, with 
each patients as a fixed effect, and the arbitrary beat-number nested under position-
position, which itself was nested under operator. Estimates of the variance 
components with associated confidence (or credible) intervals of these components 
were generated using MCMC techniques by the MCMCglmm package in R(10) (using 
default priors, number of iterations = 100,000 burn-in 15,000 thin 50). The 
measurements were log-transformed before processing to allow the variance 
components to be easily converted to coefficients of variation(6). 
These estimates were plotted individually as bar charts, but also as a series of 
nested squares (as it is the variances that are additive), along with a population 
coefficient of variation to provide context.  
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RESULTS 
Baseline characteristics 
Twenty-seven patients with aortic stenosis (Vmax mean 4.00, range 2.31 to 6.06m/s) 
were scanned between (November 2011 to June 2012) in the department where I 
worked when I was present. I worked as part of a pool of 17 operators, although 
many only worked for a short window of time during that period, or were only part 
time during the week. Each patient was scanned by a median of 3 operators (range 2 
to 4). On average 3.6 (range 1-7) runs of beats were recorded by each operator for 
each patient, consisting of a mean of 14.8 (range 1 to 51) for a total of 1880 beats. 
The baseline characteristics are in Table 1. 
Components contributing to the variability 
The overall total coefficient of variation across readers, operators, positions, and 
beats at for the aortic valve Vmax and VTI, and LVOT Vmax and VTI were 13.3% 
15.9%, 17.6%, 20.2% respectively. Figure 2 and Table 1 show its constituent parts. 
Order of priority of sources of variability 
Position was the component that on average contributed most to variability, namely a 
average coefficient of variation of 10.5%. A close second was true beat-to-beat 
difference 9.3%. Further behind came variability arising from the act of tracing, at 
7.3%. Coefficient of variation from the reader was only 4.2% on average. 
Behaviour of different parameters 
The four parameters behaved broadly similarly in the pattern above.  However, LVOT 
VTI showed a particularly large variability component attributable to tracing 11.3% 
coefficient of variation whilst the other parameters the other coefficient of variation 
were between 3.4% for the Vmax at the aortic valve and 7.1% for the VTI at the aortic 
valve. 
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Display of variability components in an understandable manner 
To help clinical echocardiographers understand the meaning of the results I am 
presenting them graphically in a way that lets the subtraction of components become 
intuitive, namely showing the variances as areas. This is shown for peak aortic 
velocity in Figure 3.  
The interpretation is as follows: 
For peak aortic velocity, the tracing variability has a coefficient of variation 3.4%. This 
is shown as a purple square whose side is 3.4%. In the experiment of changing beats 
a total variability of 9.7% is seen, of course 3.4% must be allocated tracing variability, 
and therefore only 9.0% is attributable it being a different beat. It is the squares of the 
variance that summate rather than the standard deviations. This is graphically shown 
by a larger red square with sides of length 9.7% surrounding the purple square. The 
overall area of the larger square encompasses both sources of variability and 
therefore only the outer strip of red, which is not tracing variability, is genuinely due to 
the different beats. 
This process can be repeated with progressively more sources of variability added 
until the full variability is shown for a new operator acquiring new pictures interpreted 
by a new reader that is represented by the outermost coloured square. The areas of 
colour represent the size of variance introduced by each component of variability. 
Note how once the squares get large, the addition of an additional variance 
component has less and less effect on the magnitude of the overall coefficient of 
variation. 
The corresponding “peel-away variance maps” for LVOT peak velocity, aortic VTI 
and LVOT VTI are shown in figures 3B, 3C, and 3D. 
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DISCUSSION 
The coefficient of variation was 13.3%, 15.9%, 17.6%, and 20.2% for the aortic peak 
velocity (Vmax), and velocity time integral (VTI), and left ventricular outflow tract 
(LVOT) Vmax and VTI respectively. This variability is clinically large, and larger than 
reported in the literature. It should be remembered that, this variability does not 
contain the biological components of variability that develop over a period of days. It 
only includes variability in the very short term arising from rapid biological variations 
or by the many steps of the measurement process. 
This study suggests that the usual advice given to clinicians and researchers to help 
obtain reliable measurements not accurate enough. They are typically advised to 
follow a strict protocol to try to use a consistent member of staff on each occasion for 
image acquisition, and a consistent member of staff to carry out each reading of the 
acquired images. In reality the contribution to variance made by having a different 
operator acquiring images or a different reader analysing images, is small by 
comparison to the variance introduced by the act of tracing, by spontaneous beat-to-
beat variability, and probe position during acquisition.  
 
How clinicians are advised by guidelines to reduce variability.  
Multiple readings can be combined to reduce the apparent variability of a 
measurement, and indeed guidelines bodies such as the ESC(11) and ASE(12) 
recommend averaging across three to five beats. However, they neither provide an 
estimate of what level of reproducibility before, nor after averaging. Furthermore, as I 
have shown in this thesis there are multiple sources of variability; beat-to-beat and 
biological variability at longer time-scales, intra- and inter-reader, and intra and inter-
operator. Averaging only across a few sequential beats will only reduce a few of the 
components, and the effect on the total variability will therefore less than expected. 
   18	  
For example, if three consecutive beats are averaged only the tracing and beat-to-
beat variance will be reduced by a third, rather that the total variance. In this dataset, 
this is equivalent to reducing the coefficient of variation from 13.3 to 10.3 for the 
assessment of the aortic Vmax. If however, the three beats are taken from different 
probe positions, the expected coefficient of variation will be 7.9%. Table 2 lists such 
calculations for the other parameters. 
 
Implications for clinical practice 
The maximum achievable precision 
Should the clinician wish to reduce the coefficient of variation to, for example <5%, 
he would need to average 9 beats from 9 different probe positions for the aortic Vmax. 
If however they were to follow current guidelines and only average consecutive 
beats, as the position coefficient of variation is in excess of 5% for the aortic Vmax, 
such precision could not be achieved as the position variability is 8.3% and without 
varying that it cannot be averaged out. Indeed, the theoretical best precision that 
could be achieved for the aortic Vmax with a large number of beats would be 8.6%. 
Knowledge of the true test-retest variability of a measurement and its constituent 
parts is therefore essential for both the clinician and the researcher. 
 
Advice for sonographers 
Whilst the typical advice to a sonographer who fails to match the reading produced 
by a more experienced colleague it to undergo more training, this thesis find that the 
most significant contributor to variability is not related to the reader or the operator, 
which have the smallest contribution to the overall coefficient of variation, but that of 
beat-to-beat and probe position. Consequently, as a science, efforts should be 
directed to utilising this information in developing more robust measurement 
techniques and strategies (as described below), rather than producing ever 
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expanding guidelines with recommendations that appear to be based on the belief 
that a lack of precision results from a lack of standardisation(13). 
Effect on management 
An accurate assessment of aortic stenosis severity is crucial in terms of patient’s 
management, especially when the AS is in the “grey area” between moderate and 
severe grade and a decision to refer the patient to surgery or postpone must be 
taken(14). The variability of even a simple measure like aortic Vmax will lead to 
occasional extreme values being seen that exceed a certain threshold. If guidelines 
are followed and the operator selected the highest values obtained, they would 
occasionally capture a beat with a Vmax higher than the threshold of 4m/s even 
though the vast majority of the beats are lower. Such an error could lead to a 
significant change in management (coloured in red). By requiring selection of the 
maximum value, the value selected will become dependent upon the number of 
beats examined as the operator waits for more and more extreme beats. 
Furthermore the variability of the maximum value of a distribution is greater than that 
of the mean(15). 
Both these effects conspire to further diminish the parameters reproducibility. 
 
Effect on ability to measure change 
Guidelines suggest that a combination of a markedly calcified valve with a rapid 
increase in velocity of 0.3 m/s within one year has been shown to identify a high-risk 
group of patients (about 80% death or requirement of surgery within two years). In 
light of the variability identified in this thesis, this guideline may be unwise. The 95% 
confidence interval for detecting a change is from -33% to +42% for Vmax (the 
confidence interval is symmetric on a log scale), which is larger than the approximate 
10% progression represented by 0.3 m/s in a patient with moderate aortic stenosis. If 
three consecutive beats are averaged the coefficient of variation is reduced to 10.3%, 
therefore the 95% confidence interval for a change is from -24.7% to +32.9%. 
However, if three beats from three different probe applications are used the 
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coefficient of variation becomes 7.9%, and the associated the 95% confidence 
interval for a change is from -19% to +24%. None of these confidence intervals is 
sufficiently small to allow for confident detection of a true change of 10% in maximum 
aortic velocity. 
Allows for the introduction of bias 
It has been previously demonstrated that the variability of measurements from serial 
echo data is reduced when performed unblinded to the study order and patient(16). 
Readers, when confronted with serial measurements of a parameter that they expect 
to at least stay the same and may often progress, such as with aortic stenosis will be 
reluctant to report a value that the lower that the preceding one. Errors in the 
opposite direction, however, will not be automatically detected by this process, and 
may instead be accepted as evidence of genuine deterioration. As a result, the will 
be a consistent bias towards exaggeration to the rate of progression of disease.  
 
Effect on composite measures 
If the errors are not correlated, which is unlikely as they are not acquired 
simultaneously (e.g. pulse wave and continuous wave Doppler tracings cannot be 
recorded at the same time) the reproducibility of composite measures will be worse 
than those of its constituent measurements. E.g. Whilst the coefficient of variation of 
Vmax at the aortic valve and LVOT is 13.3% and 17.6% respectively, for the 
dimensionless index the ratio of the two it would be 31%. It is even worse if VTIs are 
used - the VTI at the AV and LVOT is 15.9% and 20.2% giving a predicted coefficient 
of variation of 36% for the dimensionless index by DI. That reproducibility of the 
aortic valve area, which incorporates a third measure, that of the diameter of the 
LVOT squared, will be even worse. These calculations assume that the errors in 
measurement are completely uncorrelated. In fact it is likely that the errors LVOT and 
AV velocity are partly correlated - if an operator was particularly fastidious or lax 
about ensuring correct alignment both the AV and LVOT would likely be high or low, 
therefore, these estimates may represent the upper limit on the estimated coefficient 
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of variation. Indeed, in my retrospective analysis for real world data(1) these figures 
were lower at 13% and 25% for the dimensionless index by Vmax and VTI 
respectively.  
 
Implications for research 
Effect on studies using aortic as end-points 
Accurate assessment of the progression of aortic stenosis is crucial for determining 
the effects of potential clinical interventions on the disease as a whole. The power of 
potential future clinical trials to detect the effect of interventions on the progression of 
aortic stenosis(17) is reduced by the lack of reliability in the measurements. 
Appreciating that the agreement between two different measurement techniques is 
limited by their individual reproducibility 
The high concordance of simultaneous in vivo Doppler and dual catheter 
measurements of aortic gradients established echocardiography as the primary 
technique for the quantitative assessment of aortic stenosis(18) 
Nevertheless, even these original authors’ enthusiasm was tempered by the 
significantly worse concordance with non-simultaneous echocardiographic 
measurements(19) (such as those values obtained from the referring clinic). 
This finding is not unexpected. The analytical and biological variability of a 
measurand will naturally limit the agreement between two non-simultaneous 
techniques(20). A lack of test-retest reproducibility limits how much a variable can 
correlate with itself, let alone another noisy variable. 
Consequently, when comparing one technique with another for assessing aortic 
stenosis clinical researchers should first assess its true test-retest variability before 
pitting it against another noisy measure. 
 
Designing mechanisms to improve the precision of aortic stenosis assessment 
The comprehensive analysis provided by this thesis of the components that 
contribute to the variability of aortic stenosis assessment allows for a targeted 
approach for future improvements. Removal of the variability associated with tracing 
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and readers (intra- and inter-reader variability) should be straightforward with 
computer algorithms. Once such algorithms are in place, the unbiased analysis of 
multiple captured beats and positions becomes easier, and their associated 
variability can be reduced in proportion to the square root of the number of positions 
and beats captured. Such systems have already been developed for the mitral(21)(22) 
and other valves(23). 
Limitations 
This thesis did not examine the variability associated over time periods longer than 
the minimum to allow for at most four operators to capture continuous and pulse 
wave Doppler tracings of the aortic valve and LVOT as we had investigated this 
previously, although in a retrospective manner(1). Due to operational constraints I did 
not investigate the impact of the equipment manufacturer or training of the operator. 
This was not a multicentre study. However, whilst the coefficients of variation may 
vary from between centres due to operator experience my study did utilise 17 
different operators, some sonographers and some doctors with a range of years of 
experience since accreditation. Consequently, I expect these results to be 
generalizable to similar large echocardiography units. 
I did encounter some statistical issues. Whilst between two and four operators 
scanned each patient, within a quality improvement programme it would have been 
difficult to ensure that it were the same operators for every patient. The 
computational method and statistical package (MCMCglmm) used for solving the 
mixed model provided unstable estimates with large confidence intervals for the 
operator coefficient of variation as it was a partially crossed factor. Other authors 
have run into such issues(24), we are unaware of a straightforward, direct solution to 
this problem. Therefore, the current estimate of the true operator contribution must 
be considered as unreliable.  
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Comparison with existing literature 
Within cardiology, and much of echocardiography, such analyses are rare, though 
are not without precedent(24)(25). Often results are presented as not a standard 
deviations or coefficients of variations (or corresponding Bland-Altman limits of 
agreement), but as a regression line and correlation coefficient. Interpreting these 
can be fraught with hazards(6). Furthermore, whilst the Bland-Altman limits of 
agreement technique is a marked improvement upon reporting correlation 
coefficients and p-values it tends to lead to an experimental set-up limited to two 
specific observers, readers, or operators. This provides a good estimate for the 
agreement between the two specified operators, but may be poorly generalisable to 
multiple operators. 
This thesis therefore uniquely provides estimates for the individual contribution of 
many of the components that contribute to the variability of measurements of aortic 
stenosis. These estimates are comparable with our previous retrospective analysis(1), 
but larger than previous estimates. Other studies(26)(27) similar levels of accuracy, 
reporting a coefficient of variation for Vmax ranging from 5% to 7%. The difference for 
this is unclear. In one early study which reported a test-retest coefficient of 5%(27) 
inspection of the provided raw data shows them to be incredibly accurate. In five out 
of the twenty patients examined exactly the same Vmax to two decimal places was 
found on three independent, scans taken at baseline, one week, and one month. 
Review of the methods provides for no special techniques to improve precision; 
perhaps inadvertent unblinding could have led to their apparent accuracy. 
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CONCLUSION 
This thesis provides both an accurate assessment of the coefficient of variation that a 
typical large echocardiography department would be able to ascertain for four of the 
key parameters that are used to assess the severity of aortic stenosis. It finds that 
there reproducibility is poorer often reported in the literature, but comparable with a 
retrospective study I had previously conducted.  
This large variability for these simple parameters of Vmax and VTI at the aortic valve 
and LVOT makes composite measures for the assessment of the severity of aortic 
stenosis even more unreliable. Within clinical practice, such variability can lead to 
classification errors near the severity thresholds, or can results in inaccurate 
assessments of a progression in severity. The source of this variability does not 
appear, as traditionally believed, to result from a lack of training or inter-operator and 
inter-reader factors, but rather the beat-to-beat biological variability, and the inherent 
impossibility of applying the ultrasound probe in exactly the same position each time 
are the largest contributors. Consequently, guidelines suggesting greater 
standardisation of procedures and further training for sonographers are unlikely to 
result in an improvement in precision. 
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Table 1.    
Coefficient of 
variation 
attributable to each 
component 
Aortic  LVOT  
 Vmax VTI Vmax VTI 
Tracing 3.4% (3.3 to 3.6%) 7.1% (6.8 to 7.5%) 4.5% (4.3 to 4.7%) 
11.3% (10.7 to 
11.9%) 
Beat-to-beat 9.0% (8.4 to 9.6%) 9.3% (8.5 to 10.2%) 9.5% (8.9 to 10.2%) 9.4% (8.1 to 10.7%) 
Position 8.3% (7.2 to 9.8%) 9.4% (8.0 to 10.9%) 
12.9% (11.2 to 
14.9%) 10.7% (9 to 12.8%) 
Operator 0.6% (0.0% to 5.8%) 0.3% (0.0 to 2.4%) 0.4% (0.0 to 5.0%) 0.9% (0.0% to 7.5%) 
Reader 2.3% (1.5 to 3.6%) 3.3% (2.0 to 5.6%) 3.4% (2.2 to 5.3%) 6.6% (4. 0 to 10.7%) 
 
The values presented are the coefficients of variation attributable to each component individually. 
Number in brackets - 95% confidence interval. 
 
 
 
Table 2. 
Overall 
variability at 
each level 
Aortic  LVOT  
 Vmax VTI Vmax VTI 
Reader 13.3% 15.9% 17.6% 20.2% 
Operator 13.0% 15.5% 17.1% 18.9% 
Position 13.0% 15.5% 17.1% 18.9% 
Beat 9.7% 11.9% 10.6% 15.0% 
Tracing 3.4% 7.1% 4.5% 11.3% 
 
The overall variability at each level, which includes all the underlying levels.  
For example, the variability associated tracing around the same beet is 3.4%. If a different operator is 
used, the variability must also include that of a different position, beat, and tracing.
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Figure 1. 
 
 
This diagram above shows the potential sources of variability associated with making a measurement, 
such as the aortic valve Vmax or LVOT VTI. It shows the hierarchy of the components that contribute to 
variability. Change in one of the components will naturally lead to a change in lower down components. 
For example, if the operator is changed, then so will the probe position, beat, and tracing. If a different 
beat is selected for measurement, then a separate tracing must also occur. 
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Figure 2 
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Figure 3 A. 
 
“Peel-away plot” of the coefficient of variation for the aortic valve maximum velocity. 
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Figure 3 B. 
 
“Peel-away plot” of the coefficient of variation for the aortic valve velocity time integral. 
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Figure 3 C. 
 
“Peel-away plot” of the coefficient of variation for the LVOT maximum velocity. 
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Figure 3 D. 
 
 “Peel-away plot” of the coefficient of variation for the LVOT velocity time integral. 
 
 
 
 
